Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pantoprazole 20 mg/40 mg for the Treatment of Gastroesophageal Reflux Disease (GERD)

NCT00561730 is registered in ClinicalTrials.gov with Nycomed as lead sponsor.

NCT NCT00561730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00561730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pantoprazole 20 mg/40 mg for the Treatment of Gastroesophageal Reflux Disease (GERD)
Lead sponsor
Nycomed
Phase
Observational
Overall status
Completed
Start date
October 31, 2007
Completion date
December 31, 2008
Enrollment
1,995 (actual)
Sites
259

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease